Background. The radiobiological effects induced by spatially fractionated radiation therapy (SFRT), a specialized cancer treatment technique in which radiation is delivered in a non-uniform pattern, play a crucial role in cancer therapy. Purpose. To develop a comprehensive mathematical framework for simulating and predicting tumor volume changes following RT, encompassing both stereotactic body RT (SBRT) and SFRT. This framework will facilitate the exploration of various SFRT-SBRT combination regimens to deepen understanding of SFRT’s role in tumor treatment. Methods. The tumor cell compartments are classified into active and inactive tumor cells, the latter resulting from radiation, and modeled using ordinary differential equations. We propose a novel mathematical forecasting framework that integrates both the dynamic carrying capacity and proliferative potential of tumor cells following radiation therapy, accounting for the biological interactions between the tumor, immune system, and irradiation. Data from five patients, collected during and after RT, are used for parameter estimation, and the model is subsequently applied to predict tumor response to various SFRT-SBRT treatment regimens. Results. For the SFRT + SBRT treatment protocol, the model indicates that the time intervals between SFRT and SBRT significantly influence the treatment outcomes. A 1 month interval may represent the optimal scenario for achieving early and efficient tumor shrinkage, while an interval of less than 2 weeks could disrupt the bystander effect and the early immune response triggered by SFRT, leading to a less favorable treatment outcome. Additionally, the SFRT + SBRT protocol is generally more effective than the SBRT + SFRT protocol in controlling tumor growth. Conclusions. These results demonstrate that our comprehensive mathematical model effectively captures a range of tumor volume dynamics across different RT protocols. It enables accurate prediction of patient outcomes, which can be applied to design optimized RT plans for SBRT and SFRT, ensuring efficient tumor shrinkage.
In this paper, we construct an infectious disease model with a testing compartment and analyze the existence and stability of its endemic states. We obtain the basic reproduction number, , and demonstrate the existence of one endemic equilibrium without testing and one endemic equilibrium with testing and prove their local and global stabilities based on the value of the basic reproduction number, . We then apply our model to the US COVID-19 pandemic and find that, for a large parameter set, including those relevant to the SARS-CoV-2 virus, our analytic and numerical results suggest that the trajectories will be trapped to the testing-free state when the testing number is small enough. This indicates that the pandemic may end with a testing-free endemic state through a novel and surprising mechanism called stochastic trapping.
What is the long term dynamics of the Covid-19 pandemic? How will it end? Here we constructed an infectious disease model with testing and analyzed the existence and stability of its endemic states. For a large parameter set, including those relevant to the SARS-CoV-2 virus, we demonstrated the existence of one endemic equilibrium without testing and one endemic equilibrium with testing and proved their local and global stabilities for some cases. Our results suggest that the pandemic is to end with a testing-less endemic state through a novel and surprising mechanism called stochastic trapping.
We present a mathematical model based on ordinary differential equations to investigate the spatially homogeneous state of tumor growth under virotherapy. The model emphasizes the interaction among the tumor cells, the oncolytic viruses, and the host immune system that generates both innate and adaptive immune responses. We conduct a rigorous equilibrium analysis and derive threshold conditions that determine the growth or decay of the tumor under various scenarios. Numerical simulation results verify our analytical predictions and provide additional insight into the tumor growth dynamics.